{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:44:06Z","timestamp":1776987846743,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Breast Cancer Research Foundation, United States"},{"name":"U.S. Department of Defense, United States"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43486-9","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:55:19Z","timestamp":1773384919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial proteomics of breast ductal carcinoma in situ reveal distinct regional differences"],"prefix":"10.1038","volume":"16","author":[{"given":"Jeffrey R.","family":"Marks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine M.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunden","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel E.","family":"Factor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita K.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadee L.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander B.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouros","family":"Owzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"43486_CR1","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/jnci\/djy220","volume":"111","author":"MD Ryser","year":"2019","unstructured":"Ryser, M. D. et al. Cancer Outcomes in DCIS Patients Without Locoregional Treatment. J. Natl. Cancer Inst. 111, 952\u2013960 (2019).","journal-title":"J. Natl. Cancer Inst."},{"key":"43486_CR2","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","volume":"150","author":"Y Sagara","year":"2015","unstructured":"Sagara, Y. et al. Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study. JAMA Surg. 150, 739\u2013745 (2015).","journal-title":"JAMA Surg."},{"key":"43486_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.breast.2022.01.001","volume":"61","author":"AJ Maxwell","year":"2022","unstructured":"Maxwell, A. J. et al. Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study. Breast 61, 145\u2013155 (2022).","journal-title":"Breast"},{"key":"43486_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.2024.26698","volume":"333","author":"ES Hwang","year":"2025","unstructured":"Hwang, E. S. et al. Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial. JAMA 333, 972\u2013980 (2025).","journal-title":"JAMA"},{"key":"43486_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof, L. E. et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. Eur. J. Cancer. 51, 1497\u20131510 (2015).","journal-title":"Eur. J. Cancer"},{"key":"43486_CR6","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis, A. et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur. J. Cancer. 51, 2296\u20132303 (2015).","journal-title":"Eur. J. Cancer"},{"key":"43486_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9610(03)00265-4","volume":"186","author":"MJ Silverstein","year":"2003","unstructured":"Silverstein, M. J. The University of Southern California\/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am. J. Surg. 186, 337\u2013343 (2003).","journal-title":"Am. J. Surg."},{"key":"43486_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1200\/JCO.2011.36.4976","volume":"30","author":"M Yi","year":"2012","unstructured":"Yi, M. et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J. Clin. Oncol. 30, 600\u2013607 (2012).","journal-title":"J. Clin. Oncol."},{"key":"43486_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jnci\/djt067","volume":"105","author":"LJ Solin","year":"2013","unstructured":"Solin, L. J. et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. 105, 701\u2013710 (2013).","journal-title":"J. Natl. Cancer Inst."},{"key":"43486_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/jnci\/djq101","volume":"102","author":"K Kerlikowske","year":"2010","unstructured":"Kerlikowske, K. et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J. Natl. Cancer Inst. 102, 627\u2013637 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"43486_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13058-024-01927-1","volume":"26","author":"M Debeljak","year":"2024","unstructured":"Debeljak, M. et al. Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ. Breast Cancer Res. 26, 178 (2024).","journal-title":"Breast Cancer Res."},{"key":"43486_CR12","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.ccell.2023.06.002","volume":"41","author":"SH Strand","year":"2023","unstructured":"Strand, S. H. et al. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 41, 1381 (2023).","journal-title":"Cancer Cell."},{"key":"43486_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","volume":"185","author":"T Risom","year":"2022","unstructured":"Risom, T. et al. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell 185, 299\u2013310e18 (2022).","journal-title":"Cell"},{"key":"43486_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/978-1-4939-9773-2_25","volume":"2055","author":"JM Beechem","year":"2020","unstructured":"Beechem, J. M. High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-oncology Biomarker Discovery and Translational Research. Methods Mol. Biol. 2055, 563\u2013583 (2020).","journal-title":"Methods Mol. Biol."},{"key":"43486_CR15","unstructured":"Team, R. C. R: A language and environment for statistical computingR Foundation for Statistical Computing, Vienna, Austria,. (2022)."},{"key":"43486_CR16","doi-asserted-by":"crossref","unstructured":"Xie, Y. A. & Grolemund, J. J. G. R Markdown: The Definitive Guide (Chapman and Hall\/CRC, 2018).","DOI":"10.1201\/9781138359444"},{"key":"43486_CR17","doi-asserted-by":"crossref","unstructured":"Xie, Y. Dynamic Documents with R and knitr 2nd edn, Vol. 294 (Chapman and Hall\/CRC, 2015).","DOI":"10.1201\/b15166"},{"key":"43486_CR18","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.1310023","author":"S Developers","year":"2021","unstructured":"Developers, S. Singularity https:\/\/doi.org\/10.5281\/zenodo.1310023 (2021).","journal-title":"Singularity"},{"key":"43486_CR19","doi-asserted-by":"publisher","first-page":"e0177459","DOI":"10.1371\/journal.pone.0177459","volume":"12","author":"GM Kurtzer","year":"2017","unstructured":"Kurtzer, G. M., Sochat, V., Bauer, M. W. & Singularity Scientific containers for mobility of compute. PLoS One. 12, e0177459 (2017).","journal-title":"PLoS One"},{"key":"43486_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.bjc.6606021","volume":"104","author":"SE Clark","year":"2011","unstructured":"Clark, S. E. et al. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br. J. Cancer. 104, 120\u2013127 (2011).","journal-title":"Br. J. Cancer"},{"key":"43486_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas, N","year":"2012","unstructured":"Cancer Genome Atlas, N. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"43486_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/path.1559","volume":"203","author":"DM Abd El-Rehim","year":"2004","unstructured":"Abd El-Rehim, D. M. et al. Expression of luminal and basal cytokeratins in human breast carcinoma. J. Pathol. 203, 661\u2013671 (2004).","journal-title":"J. Pathol."},{"key":"43486_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1046\/j.1365-2559.1996.5710809.x","volume":"30","author":"S Ichihara","year":"1997","unstructured":"Ichihara, S., Koshikawa, T., Nakamura, S., Yatabe, Y. & Kato, K. Epithelial hyperplasia of usual type expresses both S100-alpha and S100-beta in a heterogeneous pattern but ductal carcinoma in situ can express only S100-alpha in a monotonous pattern. Histopathology 30, 533\u2013541 (1997).","journal-title":"Histopathology"},{"key":"43486_CR24","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41588-022-01082-3","volume":"54","author":"EH Lips","year":"2022","unstructured":"Lips, E. H. et al. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer. Nat. Genet. 54, 850\u2013860 (2022).","journal-title":"Nat. Genet."},{"key":"43486_CR25","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1158\/1078-0432.CCR-19-2563","volume":"26","author":"F Pareja","year":"2020","unstructured":"Pareja, F. et al. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma. Clin. Cancer Res. 26, 3682\u20133693 (2020).","journal-title":"Clin. Cancer Res."},{"key":"43486_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10549-019-05401-x","volume":"178","author":"CY Lin","year":"2019","unstructured":"Lin, C. Y. et al. Genomic landscape of ductal carcinoma in situ and association with progression. Breast Cancer Res. Treat. 178, 307\u2013316 (2019).","journal-title":"Breast Cancer Res. Treat."},{"key":"43486_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/modpathol.2017.21","volume":"30","author":"JB Pang","year":"2017","unstructured":"Pang, J. B. et al. Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer. Mod. Pathol. 30, 952\u2013963 (2017).","journal-title":"Mod. Pathol."},{"key":"43486_CR28","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-15-0506","volume":"75","author":"MC Abba","year":"2015","unstructured":"Abba, M. C. et al. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ. Cancer Res. 75, 3980\u20133990 (2015).","journal-title":"Cancer Res."},{"issue":"Suppl 1","key":"43486_CR29","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/S0960-9776(19)31120-8","volume":"48","author":"ES Hwang","year":"2019","unstructured":"Hwang, E. S. & Malek, V. Estimating the magnitude of clinical benefit of local therapy in patients with DCIS. Breast 48 (Suppl 1), S34\u2013S38 (2019).","journal-title":"Breast"},{"key":"43486_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13058-024-01885-8","volume":"26","author":"SH Strand","year":"2024","unstructured":"Strand, S. H. et al. Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome. Breast Cancer Res. 26, 127 (2024).","journal-title":"Breast Cancer Res."},{"key":"43486_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert, C. et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 19, 40\u201350 (2018).","journal-title":"Lancet Oncol."},{"key":"43486_CR32","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41416-022-01888-2","volume":"127","author":"MM Almekinders","year":"2022","unstructured":"Almekinders, M. M. et al. Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk. Br. J. Cancer. 127, 1201\u20131213 (2022).","journal-title":"Br. J. Cancer"},{"key":"43486_CR33","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41388-024-02973-x","volume":"43","author":"SE Reid","year":"2024","unstructured":"Reid, S. E. et al. Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence. Oncogene 43, 1113\u20131126 (2024).","journal-title":"Oncogene"},{"key":"43486_CR34","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/2159-8290.CD-23-0426","volume":"14","author":"J Ye","year":"2024","unstructured":"Ye, J. et al. Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression. Cancer Discov. 14, 1302\u20131323 (2024).","journal-title":"Cancer Discov"},{"key":"43486_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41523-020-0167-x","volume":"6","author":"H Bergholtz","year":"2020","unstructured":"Bergholtz, H. et al. Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions. NPJ Breast Cancer. 6, 26 (2020).","journal-title":"NPJ Breast Cancer"},{"key":"43486_CR36","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/PAS.0000000000001300","volume":"43","author":"Y Horimoto","year":"2019","unstructured":"Horimoto, Y. et al. Estrogen Receptor-positive Ductal Carcinoma In Situ Frequently Overexpresses HER2 Protein Without Gene Amplification. Am. J. Surg. Pathol. 43, 1221\u20131228 (2019).","journal-title":"Am. J. Surg. Pathol."},{"key":"43486_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1186\/s12885-022-09883-9","volume":"22","author":"SL Wu","year":"2022","unstructured":"Wu, S. L., Yu, X., Mao, X. & Jin, F. Prognostic value of tumor-infiltrating lymphocytes in DCIS: a meta-analysis. BMC Cancer. 22, 782 (2022).","journal-title":"BMC Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43486-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43486-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43486-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:23:50Z","timestamp":1776986630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43486-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43486"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43486-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13350"}}